** = Publikationen gelistet in SCI/SSCI/Pubmed
** Torreiter, PP; Macher, S; Matzhold, EM; Resch, B; Klaritsch, P; Kormoczi, GF; Polin, H; Neuhold, L; Schonbacher, M; Schlenke, P; Wagner, T
Ethical Issues and Management of Fetal Hemolytic Anemia Caused by Anti-Rh17 in a Multipara with Rare -D- Phenotype
TRANSFUS MED HEMOTH. 2021;
Doi: 10.1159/000513124
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Drexler, C; Macher, S; Lindenau, I; Holter, M; Moritz, M; Stojakovic, T; Pieber, TR; Schlenke, P; Amrein, K
High-dose intravenous versus oral iron in blood donors with iron deficiency: The IronWoMan randomized, controlled clinical trial.
Clin Nutr. 2020; 39(3):737-745
Doi: 10.1016/j.clnu.2019.03.025
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Macher, S; Herster, C; Holter, M; Moritz, M; Matzhold, EM; Stojakovic, T; Pieber, TR; Schlenke, P; Drexler, C; Amrein, K
The Effect of Parenteral or Oral Iron Supplementation on Fatigue, Sleep, Quality of Life and Restless Legs Syndrome in Iron-Deficient Blood Donors: A Secondary Analysis of the IronWoMan RCT.
Nutrients. 2020; 12(5):
Doi: 10.3390/nu12051313
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Müller, M; Graf, R; Kashofer, K; Macher, S; Wölfler, A; Zebisch, A; Hrzenjak, A; Heitzer, E; Sill, H
Detection of AML-specific TP53 mutations in bone marrow-derived mesenchymal stromal cells cultured under hypoxia conditions.
Ann Hematol. 2019; 98(8):2019-2020
Doi: 10.1007/s00277-019-03680-4
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Matzhold, EM; Polin, H; Körmöczi, GF; Macher, S; Schönbacher, M; Wagner, T
RHD del28Phe (DMW) encoded by a novel in-frame deletion resulting in reduced D antigen expression.
Transfusion. 2019; 59(9):3033-3034
Doi: 10.1111/trf.15459
(- Case Report)
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Amrein, K; Macher, S; Schröck, M; Schlenke, P; Drexler, C
Iron deficiency in blood donors: perceptions and management among general practitioners and internists.
Transfusion. 2017; 57(10): 2548-2549.
Doi: 10.1111/trf.14297
Web of Science
PubMed
FullText
FullText_MUG
** Macher, S; Drexler, C; Lindenau, I; Sareban, N; Schlenke, P; Amrein, K
High-dose intravenously administered iron versus orally administered iron in blood donors with iron deficiency: study protocol for a randomised, controlled trial.
Trials. 2016; 17(1):527-527
Doi: 10.1186/s13063-016-1648-y
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Macher, S; Wagner, T; Rosskopf, K; Reiterer, F; Csapo, B; Schlenke, P; Klaritsch, P
Severe case of fetal hemolytic disease caused by anti-C(w) requiring serial intrauterine transfusions complicated by pancytopenia and cholestasis.
Transfusion. 2016; 56(1):80-83
Doi: 10.1111/trf.13367
(- Case Report)
Web of Science
PubMed
FullText
FullText_MUG
** Amrein, K; Drexler, C; Macher, S; Schlenke, P; Schrock, M
Perceptions and management of iron deficiency in blood donors among general practitioners and internists
WIEN KLIN WOCHENSCHR. 2016; 128: S379-S379.-ÖGIM Jahrestagung; SEP; Salzburg, AUSTRIA.
[Poster]
Web of Science
** Macher, S; Zinke-Cerwenka, W; Posch, U; Ulrich, S; Sipurzynski, S; Greinix, H; Schlenke, P
Thrombozytenrefraktärität durch Anti-HPA 3a bei Zustand nach allogener Blutstammzelltransplantation: ein Fallbericht.
TRANSPL INT. . 2016; 29(s4):21-21.-Austrostransplant 2016; OCT 19-21, 2016; Schladming, AUSTRIA.
[Poster]
Web of Science
** Sareban, N; Macher, S; Drexler, C; Posch, U; Lanzer, G; Schallmoser, K
Platelet antibody analysis by three different tests.
J Clin Lab Anal. 2015; 29(3):198-202
Doi: 10.1002/jcla.21750
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Macher, S; Drexler, C; Stojakovic, T; Lindenau, I; Schrock, M; Reinprecht, C; Sareban, N; Amrein, K
INTRAVENOUS HIGH-DOSE IRON SUPPLEMENTATION FOR BLOOD DONORS WITH IRON DEFICIENCY
HAEMATOLOGICA. 2015; 100: 140-140.-20th Congress of European-Hematology-Association; JUN 11-14, 2015; Vienna, AUSTRIA.
[Poster]
Web of Science
** Macher, S; Sipurzynski-Budraβ, S; Rosskopf, K; Semmelrock, M; Prüller, F; Griesbacher, A; Lanzer, G; Schallmoser, K
Influence of multicomponent apheresis on donors' haematological and coagulation parameters, iron storage and platelet function.
Vox Sang. 2012; 103(3):194-200
Doi: 10.1111/j.1423-0410.2012.01609.x
Web of Science
PubMed
FullText
FullText_MUG
** Macher, S; Sareban, N; Drexler, C; Lanzer, G; Schallmoser, K;
Single Center Experience with the Nanoparticle-Based Flow Immunoassay for Diagnosis of Heparin-Induced Thrombocytopenia (HIT).
BLOOD. BLOOD120: WASHINGTON: AMER SOC HEMATOLOGY; ( Presented at: 54th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH), Atlanta, GA, DEC 08-11, 2012)
Doi: 10.1182/blood.V120.21.2189.2189
[Poster]
Web of Science
FullText
FullText_MUG
** Prüller, F; Drexler, C; Archan, S; Macher, S; Raggam, RB; Mahla, E
Low platelet reactivity is recovered by transfusion of stored platelets: a healthy volunteer in vivo study.
J Thromb Haemost. 2011; 9(8):1670-1673
Doi: 10.1111/j.1538-7836.2011.04392.x
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Macher, S; Sipurzynski-Budraß, S; Rosskopf, K; Rohde, E; Griesbacher, A; Groselj-Strele, A; Lanzer, G; Schallmoser, K
Function and activation state of platelets in vitro depend on apheresis modality.
Vox Sang. 2010; 99(4): 332-340.
Doi: 10.1111/j.1423-0410.2010.01353.x
Web of Science
PubMed
FullText
FullText_MUG
** Macher, S; Sipurzynski, S; Rosskopf, K; Rohde, E; Groselj-Strele, A; Griesbacher, A; Lanzer, G; Schallmoser, K
HIGH ACTIVATION STATE OF APHERESIS PLATELETS AFTER LOW VOLUME CENTRIFUGATION DURING MULTICOMPONENT COLLECTION
HAEMATOL-HEMATOL J. 2010; 95: 1058-
[Poster]
Web of Science
** Macher, S; Sipurzynski, S; Rosskopf, K; Rohde, E; Groselj-Strele, A; Griesbacher, A; Lanzer, G; Schallmoser, K
High ex vivo activation state of platelets after apheresis due to low-volume centrifugation during multicomponent collection
BONE MARROW TRANSPLANT. 2010; 45: S382-S383.
[Poster]
Web of Science
** Macher, S; Sipurzynski, S; Rosskopf, K; Rohde, E; Groselj-Strele, A; Griesbacher, A; Lanzer, G; Schallmoser, K
HIGHER ACTIVATION STATE OF PLATELETS AFTER APHERESIS: EVIDENCE FOR AN IMPACT OF LOW VOLUME CENTRIFUGATION
VOX SANG. 2010; 99: 168-168.
[Poster]
Web of Science
** Schallmoser, K; Kutschera, J; Macher, S; Ulrich, S; Eichler, P; Panzer, S; Lanzer, G
Delayed detectability of anti-HPA-3a by the MAIPA assay in a severe neonatal alloimmune thrombocytopenia, but successful transfusion of incompatible donor platelets: a case report.
Vox Sang. 2006; 91(2):181-183
Doi: 10.1111/j.1423-0410.2006.00809.x
(- Case Report)
Web of Science
PubMed
FullText
FullText_MUG
** Sipurzynski-Budrass, S; Macher, S; Haeusler, M; Lanzer, G
Successful treatment of premature rupture of membranes after genetic amniocentesis by intra-amniotic injection of platelets and cryoprecipitate (amniopatch): a case report.
VOX SANG. 2006; 91(1): 88-90.
Doi: 10.1111/j.1423-0410.2006.00784.x
(- Case Report)
Web of Science
PubMed
FullText
FullText_MUG
** Wagner, T; Macher, S; Kröll, W; Jüngling, G; Lanzer, G; Gabriel, C
Recipient-derived clots in red blood cells during transfusion.
TRANSFUSION. 2006; 46(9): 1646-1646.
Doi: 10.1111/j.1537-2995.2006.00951.x
Web of Science
PubMed
FullText
FullText_MUG
** Lassnig, R; Sovinz, P; Macher, S; Lackner, H; Schwinger, W; Dornbusch, HJ; Benesch, M; Lanzer, G; Urban, C
Granulocyte transfusions in patients with unrelated stem cell transplantation and sepsis refractory to conservative treatment
BONE MARROW TRANSPLANT. 37: S182-S182.-32nd Annual Meeting of the European-Group-for-Blood-and-Morrow-Transplantation/22nd Meeting of the EBMT-Nures-Group/5th Meeting of the EMBT-Data-Management-Group; MAR 19-22, 2006; Hamburg, GERMANY.
[Poster]
Web of Science
** Macher, S; Schallmoser, K; Sipurzynski, S; Rosskopf, K; Lanzer, G
Multicomponent apheresis with two different cell separators: Comparison of platelet function and metabolic parameters
TRANSFUSION. 2006; 46(9):41A-41A.-American Association of Blood Banks (AABB) 59th Annual Meeting; OCT 21-24, 2006; Miami Beach, Florida, USA.
[Poster]
Web of Science
** Schallmoser, K; Macher, S; Drexler, C; Panzer, S; Lanzer, G
Specific IgG antibodies against Heparin/Platelet Factor 4 complex in surgical and medical patients tested by ELISA and particle gel immunoassay.
Transfusion. 2006; 46(9): 121A
[Poster]
Web of Science
** Schallmoser, K; Macher, S; Sipurzynski, S; Rosskopf, K; Lanzer, G
Activation markers and function of platelets collected by multicomponent apheresis with two different devices during seven days of storage
TRANSFUSION. 2006; 46(9):30A-31A.-American Association of Blood Banks (AABB) 59th Annual Meeting; OCT 21-24, 2006; Miami Beach, Florida, USA.
[Oral Communication]
Web of Science
** Schallmoser, K; Rosskopf, K; Macher, S; Stubenrauch, M; Lanzer, G
Automatic platelet concentrate preparation induces higher recovery of platelets
BONE MARROW TRANSPLANT. 37: S301-S302.-32nd Annual Meeting of the European-Group-for-Blood-and-Morrow-Transplantation/22nd Meeting of the EBMT-Nures-Group/5th Meeting of the EMBT-Data-Management-Group; MAR 19-22, 2006; Hamburg, GERMANY.
[Poster]
Web of Science
** Macher, S; Schallmoser, K; Staber, PB; Neumeister, P; Posch, U; Lanzer, G; Panzer, S
Severe thrombocytopenia due to host-derived anti-HPA-1a after non-myeloablative allogeneic haematopoietic stem cell transplantation for multiple myeloma: a case report.
VOX SANG. 2005; 89(4): 257-260.
Doi: 10.1111/j.1423-0410.2005.00692.x
(- Case Report)
Web of Science
PubMed
FullText
FullText_MUG
** Macher, S; Schallmoser, K; Staber, P; Neumeister, P; Rosskopf, K; Posch, U; Panzer, S; Lanzer, G
Severe immune thrombocytopenia due to HPA-1 a host-derived antibodies after non-myeloablative allogeneic hematopoetic stem cell transplantation for multiple myeloma
TRANSFUSION 2005 45: 114A-114A.
Web of Science
** Schallmoser, K; Kutschera, J; Macher, S; Posch, U; Panzer, S; Lanzer, G
A case of neonatal alloimmune thrombocytopenia likely caused by anti-HPA-3a
TRANSFUSION 2005 45: 116A-116A.
Web of Science
** Schallmoser, K; Macher, S; Walcher, W; Lanzer, G
Detection of neonatal alloimmune thrombocytopenia (NAIT) by screening of cord blood samples
TRANSFUSION 2005 45: 116A-117A.
Web of Science
** Schallmoser, K; Rosskopf, K; Macher, S; Stubenrauch, M; Lanzer, G
Comparison of platelet concentrates from pooled buffy coats prepared automatically by the OrbiSac system and conventionally produced platelet concentrates
TRANSFUSION 2005 45: 67A-68A.
Web of Science
** Gilli, R; Macher, S; Posch, U; Rosskopf, K; Schallmoser, K; Sipurzynski, S; Wagner, T; Wasler, A; Tscheliessnigg, K; Lanzer, G
Feasibility of extracorporal photopheresis in patients after heart transplantation
TRANSFUSION 2001 41: 43S-43S.
Web of Science
** Schallmoser, K; Wagner, T; Rosskopf, K; Macher, S; Posch, U; Gilli, R; Sipurzynski, S; Lanzer, G
Alloimmunization after RhD-incompatible platelet transfusions
TRANSFUSION. 2001; 41: 105S-105S.-54th Annual Meeting; OKT 13-17, 2001; San Antonio, TX, USA.
Web of Science